Literature DB >> 11172807

The dimerization motif of cytosolic sulfotransferases.

E V Petrotchenko1, L C Pedersen, C H Borchers, K B Tomer, M Negishi.   

Abstract

Cytosolic sulfotransferases sulfate steroids such as estrogens and hydroxysteroids. The enzymes, including human estrogen sulfotransferase (hEST) and hydroxysteroid sulfotransferase (hHST), are generally homodimers in solution with mouse estrogen sulfotransferase (mEST) being one of few exceptions. To identify the amino acid residues responsible for the dimerization, eight residues on the surface of hEST were mutated to their counterparts in mEST and mutated hESTs were then analyzed by gel filtration chromatography. A single mutation of Val(269) to Glu was sufficient to convert hEST to a monomer and the corresponding mutation of Val(260) also altered hHST to a monomer. The hHST crystal structure revealed a short stretch of peptide with the side-chains from two hHST monomers forming a hydrophobic zipper-like structure enforced by ion pairs at both ends. This peptide consisted of 10 residues near the C-terminus that, including the critical Val residue, is conserved as KXXXTVXXXE in nearly all cytosolic sulfotransferases. When mEST underwent the double mutations Pro269Thr/Glu270Val dimerization resulted. Thus, the KXXXTVXXXE sequence appears to be the common protein-protein interaction motif that mediates the homo- as well as heterodimerization of cytosolic sulfotransferases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172807     DOI: 10.1016/s0014-5793(01)02129-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin.

Authors:  Odile Cérède; Jean François Dubremetz; Daniel Bout; Maryse Lebrun
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

2.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

Review 3.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Oligomerization of Sulfolobus solfataricus signature amidase is promoted by acidic pH and high temperature.

Authors:  Anna Scotto D'Abusco; Rita Casadio; Gianluca Tasco; Laura Giangiacomo; Anna Giartosio; Valentina Calamia; Stefania Di Marco; Roberta Chiaraluce; Valerio Consalvi; Roberto Scandurra; Laura Politi
Journal:  Archaea       Date:  2005-12       Impact factor: 3.273

5.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

6.  Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010-12

7.  An unusually small dimer interface is observed in all available crystal structures of cytosolic sulfotransferases.

Authors:  Brian Weitzner; Thomas Meehan; Qifang Xu; Roland L Dunbrack
Journal:  Proteins       Date:  2009-05-01

8.  The gate that governs sulfotransferase selectivity.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-12-28       Impact factor: 3.162

9.  Modification of the catalytic function of human hydroxysteroid sulfotransferase hSULT2A1 by formation of disulfide bonds.

Authors:  Xiaoyan Qin; Lynn M Teesch; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2013-02-26       Impact factor: 3.922

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.